{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:09:41Z","timestamp":1757624981822,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,9]]},"DOI":"10.7759\/cureus.91920","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:40:01Z","timestamp":1757436001000},"source":"Crossref","is-referenced-by-count":0,"title":["Mortality Trends and Demographic Disparities Among Patients With Lymphoid Leukemia and Septicemia"],"prefix":"10.7759","author":[{"given":"Hiral","family":"Undhad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simranjeet","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1437869","article-title":"Causal pathways in lymphoid leukemia: the gut microbiota, immune cells, and serum metabolites","volume":"15","author":"Zhuang X","year":"2024","unstructured":"Zhuang X, Yin Q, Yang R, Man X, Wang R, Geng H, Shi Y. Causal pathways in lymphoid leukemia: the gut microbiota, immune cells, and serum metabolites. Front Immunol. 2024, 15:1437869. 10.3389\/fimmu.2024.1437869","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-7-199810010-00010","article-title":"Infections in patients with chronic lymphocytic leukemia treated with fludarabine","volume":"129","author":"Anaissie EJ","year":"1998","unstructured":"Anaissie EJ, Kontoyiannis DP, O'Brien S, Kantarjian H, Robertson L, Lerner S, Keating MJ. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med. 1998, 129:559-66. 10.7326\/0003-4819-129-7-199810010-00010","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1555949","article-title":"Analysis of lymphocytic leukemia trends among gender, race, age, and regional groups in the U.S. between 1999-2022: a CDC-WONDER database study","volume":"15","author":"Blee S","year":"2025","unstructured":"Blee S, Weng B, Billion T, Jabbar AB, Tauseef A, Mirza M. Analysis of lymphocytic leukemia trends among gender, race, age, and regional groups in the U.S. between 1999-2022: a CDC-WONDER database study. Front Oncol. 2025, 15:1555949. 10.3389\/fonc.2025.1555949","journal-title":"Front Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04932-0","article-title":"Sepsis mortality among patients with haematological malignancy admitted to intensive care 2000-2022: a binational cohort study","volume":"28","author":"MacPhail A","year":"2024","unstructured":"MacPhail A, Dendle C, Slavin M, Weinkove R, Bailey M, Pilcher D, McQuilten Z. Sepsis mortality among patients with haematological malignancy admitted to intensive care 2000-2022: a binational cohort study. Crit Care. 2024, 28:148. 10.1186\/s13054-024-04932-0","journal-title":"Crit Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204124","article-title":"National trends and disparities in sepsis-related mortality in adults with hematological cancers, 1999-2020","volume":"144","author":"Orhin AE","year":"2024","unstructured":"Orhin AE, Gyato A, Ohene A, Otoo SD, Assabill F, Akoto NA, Khanapara D. National trends and disparities in sepsis-related mortality in adults with hematological cancers, 1999-2020. Blood. 2024, 144:5176. 10.1182\/blood-2024-204124","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2009.12.002","article-title":"Therapy of chronic lymphocytic leukaemia","volume":"23","author":"Hallek M","year":"2010","unstructured":"Hallek M. Therapy of chronic lymphocytic leukaemia. Best Pract Res Clin Haematol. 2010, 23:85-96. 10.1016\/j.beha.2009.12.002","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2007.00001.x","article-title":"U.S. Federal Regulations for emergency research: a practical guide and commentary","volume":"15","author":"McRae A","year":"2008","unstructured":"McRae A, Weijer C. U.S. Federal Regulations for emergency research: a practical guide and commentary. Acad Emerg Med. 2008, 15:88-97. 10.1111\/j.1553-2712.2007.00001.x","journal-title":"Acad Emerg Med"},{"key":"ref8","unstructured":"CDC WONDER. (2018). https.\/\/wonder.cdc.gov\/?utm_source=chatgpt.com."},{"key":"ref9","unstructured":"International Classification of Diseases (ICD-10). (2024). https.\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm\/index.html."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-022-01878-9","article-title":"Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients","volume":"51","author":"Abdel-Azim N","year":"2023","unstructured":"Abdel-Azim N, Alkilany LF, Hassan ZK, Gaber N. Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients. Infection. 2023, 51:203-11. 10.1007\/s15010-022-01878-9","journal-title":"Infection"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.071","article-title":"Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis","volume":"9","author":"Morrison VA","year":"2009","unstructured":"Morrison VA. Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis. Clin Lymphoma Myeloma. 2009, 9:365-70. 10.3816\/CLM.2009.n.071","journal-title":"Clin Lymphoma Myeloma"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2005.12.013","article-title":"Infectious complications of chronic lymphocytic leukemia","volume":"33","author":"Wadhwa PD","year":"2006","unstructured":"Wadhwa PD, Morrison VA. Infectious complications of chronic lymphocytic leukemia. Semin Oncol. 2006, 33:240-9. 10.1053\/j.seminoncol.2005.12.013","journal-title":"Semin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.332","article-title":"Management of infectious complications in patients with chronic lymphocytic leukemia","author":"Morrison VA","year":"2007","unstructured":"Morrison VA. Management of infectious complications in patients with chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2007, 332-8. 10.1182\/asheducation-2007.1.332","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2012.070","article-title":"Infectious complications in chronic lymphocytic leukemia","volume":"4","author":"Nosari A","year":"2012","unstructured":"Nosari A. Infectious complications in chronic lymphocytic leukemia. Mediterr J Hematol Infect Dis. 2012, 4:e2012070. 10.4084\/MJHID.2012.070","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600555819","article-title":"Sex differences in incidence and outcome of chronic lymphocytic leukemia patients","volume":"47","author":"Molica S","year":"2006","unstructured":"Molica S. Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. Leuk Lymphoma. 2006, 47:1477-80. 10.1080\/10428190600555819","journal-title":"Leuk Lymphoma"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002026","article-title":"Rural patients with severe sepsis or septic shock who bypass rural hospitals have increased mortality: an instrumental variables approach","volume":"45","author":"Mohr NM","year":"2017","unstructured":"Mohr NM, Harland KK, Shane DM, Ahmed A, Fuller BM, Ward MM, Torner JC. Rural patients with severe sepsis or septic shock who bypass rural hospitals have increased mortality: an instrumental variables approach. Crit Care Med. 2017, 45:85-93. 10.1097\/CCM.0000000000002026","journal-title":"Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001004","article-title":"Institutional structures and processes to support sepsis care: a multihospital study","volume":"5","author":"L\u00f3ser MK","year":"2023","unstructured":"L\u00f3ser MK, Horowitz JK, England P, et al.. Institutional structures and processes to support sepsis care: a multihospital study. Crit Care Explor. 2023, 5:e1004. 10.1097\/CCE.0000000000001004","journal-title":"Crit Care Explor"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/OP.24.00081","article-title":"Palliative and end-of-life care in hematologic malignancies: progress and opportunities","volume":"20","author":"Tsang M","year":"2024","unstructured":"Tsang M, LeBlanc TW. Palliative and end-of-life care in hematologic malignancies: progress and opportunities. JCO Oncol Pract. 2024, 20:739-41. 10.1200\/OP.24.00081","journal-title":"JCO Oncol Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-007-9097-2","article-title":"Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002","volume":"19","author":"Yamamoto JF","year":"2008","unstructured":"Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008, 19:379-90. 10.1007\/s10552-007-9097-2","journal-title":"Cancer Causes Control"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/403308-mortality-trends-and-demographic-disparities-among-patients-with-lymphoid-leukemia-and-septicemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:40:03Z","timestamp":1757436003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/403308-mortality-trends-and-demographic-disparities-among-patients-with-lymphoid-leukemia-and-septicemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.91920","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,9]]}}}